Peter Winocour

4.3k citations

118 papers · 3.2k indexed · 1 hit paper · h-index 29

Impact in

Clinical Biochemistry top 0.5%
- Paraoxonase enzyme and polymorphisms
- Advanced Glycation End Products research
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 75
- Diabetes Treatment and Management 29
- Diabetes Management and Research 28
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
Nephrology 21
- Chronic Kidney Disease and Diabetes 15

Co-authors: Ken Farrington (10 shared papers)Dhruv K. Singh (10 shared papers)Deepak Bhatnagar (15 shared papers)Paul N. Durrington (11 shared papers)Sharon Arrol (9 shared papers)M F Laker (11 shared papers)Monica Ishola (6 shared papers)Michael I. Mackness (3 shared papers)
Journals: Diabetic Medicine (23 papers)Diabetes Research and Clinical Practice (8 papers)Atherosclerosis (6 papers)Clinical Medicine (5 papers)Postgraduate Medical Journal (4 papers)
Partner nations: United Kingdom Australia Iran

In The Last Decade

Peter Winocour

111 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus 1991 · 421 citations

Peers

Countries citing papers authored by Peter Winocour

Since Specialization

Citations

This map shows the geographic impact of Peter Winocour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Winocour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Winocour more than expected).

Fields of papers citing papers by Peter Winocour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Winocour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Winocour. The network helps show where Peter Winocour may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Winocour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Winocour Line = papers co-authored together Peter Winocour links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Atherosclerosis ·Michael I. Mackness, D. W. S. Harty, Deepak Bhatnagar, Peter Winocour, Sharon Arrol, Monica Ishola, Paul N. Durrington Hit paper breakdown →	1991	421
2	Oxidative stress in early diabetic nephropathy: fueling the fire Nature Reviews Endocrinology ·Dhruv K. Singh, Peter Winocour, Ken Farrington	2010	303
3	Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy Nature Clinical Practice Nephrology ·Dhruv K. Singh, Peter Winocour, Ken Farrington	2008	165
4	Microalbuminuria and associated cardiovascular risk factors in the community Atherosclerosis ·Peter Winocour, J. Harland, J. P. Millar, M F Laker, K G Alberti	1992	130
5	Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation Kidney International ·Coralie Bingham, Sian Ellard, William G. van’t Hoff, H. Anne Simmonds, Anthony M. Marinaki, Michael K. Badman, Peter Winocour, Amanda Stride, Christopher R. Lockwood, Anthony J. Nicholls, Katharine R. Owen, Ghislaine Spyer, Ewan R. Pearson, Andrew T. Hattersley	2003	110
6	Relation of Lipid Peroxides to Macrovascular Disease in Type 2 Diabetes Diabetic Medicine ·Elsy Velázquez, Peter Winocour, Patrick Kesteven, Albert Kamanyi, M F Laker	1991	100
7	Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. BMJ ·Peter Winocour, Paul N. Durrington, M. Ishola, David C. Anderson, H. Cohen	1987	96
8	Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association Postgraduate Medical Journal ·D. J. Betteridge, P M Dodson, P.N. Durrington, Elizabeth Hughes, M F Laker, DP Nicholls, J A Rees, Carol A. Seymour, G. R. Thompson, A F Winder, Peter Winocour, Richard Wray	1993	96
9	Erythropoietic stress and anemia in diabetes mellitus Nature Reviews Endocrinology ·Dhruv K. Singh, Peter Winocour, Ken Farrington	2009	92
10	Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. Journal of Epidemiology & Community Health ·Nigel Unwin, J. Harland, Martin White, Raj Bhopal, Peter Winocour, Patricia Stephenson, Wilbur H. Watson, Catherine Turner, K. G. M. M. Alberti	1997	76
11	Effective diabetes care: a need for realistic targets BMJ ·Peter Winocour	2002	74
12	Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Murray Stewart, M F Laker, R.G. Dyer, Frances L. Game, J Mitcheson, Peter Winocour, K. G. M. M. Alberti	1993	72
13	Diabetes and chronic kidney disease: an increasingly common multi‐morbid disease in need of a paradigm shift in care Diabetic Medicine ·Peter Winocour	2017	71
14	Placebo‐controlled Trial of the Effects of Guar Gum and Metformin on Fasting Blood Glucose and Serum Lipids in Obese, Type 2 Diabetic Patients Diabetic Medicine ·Brian Lalor, Deepak Bhatnagar, Peter Winocour, M. Ishola, Sharon Arrol, M. Brading, Paul N. Durrington	1990	54
15	Simvastatin in non-insulin-dependent diabetes mellitus: Effect on serum lipids, lipoproteins and haemostatic measures Diabetes Research and Clinical Practice ·Martyn Farrer, Peter Winocour, Kevin Evans, H. A. W. Neil, M F Laker, Patrick Kesteven, K G Alberti	1994	47
16	Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021 BMC Nephrology ·Debasish Banerjee, Peter Winocour, Tahseen A Chowdhury, P. De, Mona Wahba, Rosa Montero, Damian Fogarty, Andrew Frankel, Janaka Karalliedde, Patrick B. Mark, Dipesh Patel, Ana Pokrajac, Adnan Sharif, Sagen Zac‐Varghese, Steve Baín, Indranil Dasgupta	2022	46
17	Lipoprotein (a) and Microvascular Disease in Type 1 (Insulin‐dependent) Diabetes Diabetic Medicine ·Peter Winocour, Deepak Bhatnagar, M. Ishola, Sharon Arrol, Paul N. Durrington	1991	45
18	Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Peter Winocour, Paul N. Durrington, Deepak Bhatnagar, M. Ishola, Sharon Arrol, M. Mackness	1992	44
19	Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·M. Farrer, Frances L. Game, C Albers, H. A. W. Neil, Peter Winocour, M F Laker, P C Adams, K. G. M. M. Alberti	1994	43
20	The fifth UK paediatric diabetes services survey: meeting guidelines and recommendations? Archives of Disease in Childhood ·C. Gosden, Julie Edge, Richard I. G. Holt, J. James, Bridget Turner, Peter Winocour, Chris Walton, Dinesh Nagi, Rhys Williams, K. Matyka	2010	41

About Peter Winocour

Peter Winocour is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Obstetrics and Gynecology and Surgery, having authored 118 papers that have together received 3.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (29 papers), Diabetes Management and Research (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Chronic Kidney Disease and Diabetes (15 papers), Lipoproteins and Cardiovascular Health (14 papers), Chronic Disease Management Strategies (9 papers), Diabetes and associated disorders (8 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Clinical Biochemistry (599 citations), Endocrinology, Diabetes and Metabolism (1.3k citations), Nephrology (514 citations), Biochemistry (177 citations) and Biochemistry (125 citations). Peter Winocour has collaborated with scholars based in United Kingdom, Australia and Iran. Frequent co-authors include Ken Farrington, Dhruv K. Singh, Deepak Bhatnagar, Paul N. Durrington, Sharon Arrol, M F Laker, Monica Ishola, Michael I. Mackness, David C. Anderson and D. W. S. Harty. Their work appears in journals such as Diabetic Medicine, Diabetes Research and Clinical Practice, Atherosclerosis, Clinical Medicine and Postgraduate Medical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact